Operator: Welcome to the Calliditas Therapeutics Q4 2023 Report. For the first part of the conference call, the participants will be in listen-only mode.
Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q2 2022 Earnings Conference Call August 4, 2022 08:00 ET Company Participants Jessica Breu - Head, Investor Relations and Communications Daniel Vitt -.